These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 8385880

  • 21. Foscarnet prophylaxis of cytomegalovirus infections in patients undergoing allogeneic bone marrow transplantation (BMT): a dose-finding study.
    Bregante S, Bertilson S, Tedone E, Van Lint MT, Trespi G, Mordini N, Berisso G, Gualandi F, Lamparelli T, Figari O, Benvenuto F, Raiola AM, Bacigalupo A.
    Bone Marrow Transplant; 2000 Jul; 26(1):23-9. PubMed ID: 10918402
    [Abstract] [Full Text] [Related]

  • 22. Ganciclovir implants: one year later.
    Cadman J.
    GMHC Treat Issues; 1997 Jul; 11(4/5):3-6. PubMed ID: 11364375
    [Abstract] [Full Text] [Related]

  • 23. [Ganciclovir-resistant cytomegalovirus infection: 2 cases with different clinical impact].
    Reusser P, Hostettler B, Attehbofer R.
    Schweiz Med Wochenschr; 1996 Oct 19; 126(42):1779-84. PubMed ID: 8966510
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Resistance to combined ganciclovir and foscarnet therapy in a liver transplant recipient with possible dual-strain cytomegalovirus coinfection.
    Rodriguez J, Casper K, Smallwood G, Stieber A, Fasola C, Lehneman J, Heffron T.
    Liver Transpl; 2007 Oct 19; 13(10):1396-400. PubMed ID: 17902124
    [Abstract] [Full Text] [Related]

  • 29. Reduced dose of foscarnet as preemptive therapy for cytomegalovirus infection following reduced-intensity cord blood transplantation.
    Narimatsu H, Kami M, Kato D, Matsumura T, Murashige N, Kusumi E, Yuji K, Hori A, Shibata T, Masuoka K, Wake A, Miyakoshi S, Morinaga S, Taniguchi S.
    Transpl Infect Dis; 2007 Mar 19; 9(1):11-5. PubMed ID: 17313465
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Response of asymptomatic cytomegalovirus viraemia to oral ganciclovir 3 g/day or 6 g/day in HIV-infected patients.
    Grzywacz M, Deayton JR, Bowen EF, Wilson P, Emery VC, Johnson MA, Griffiths PD.
    J Med Virol; 1999 Nov 19; 59(3):323-8. PubMed ID: 10502264
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Combined foscarnet -ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation (Hsct).
    Bacigalupo A, Bregante S, Tedone E, Isaza A, Van Lint MT, Moro F, Trespi G, Occhini D, Gualandi F, Lamparelli T, Marmont AM.
    Bone Marrow Transplant; 1996 Nov 19; 18 Suppl 2():110-4. PubMed ID: 8932810
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The progressive outer retinal necrosis syndrome: successful treatment with combination antiviral therapy.
    Ciulla TA, Rutledge BK, Morley MG, Duker JS.
    Ophthalmic Surg Lasers; 1998 Mar 19; 29(3):198-206. PubMed ID: 9547773
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.